Generic Drug articles & resources on Made-in-China.com

International Paper Bids Over Eur 8.1bn for Irish Packaging Giant Smurfit Kappa

Apr 14, 2015

US-based paper packaging company International Paper is said to be exploring a takeover bid of over €8.1bn for Irish packaging giant Smurfit Kappa. Sky News quoted a source as saying that International Paper was considering an ...

Tags: International Paper, Smurfit Kappa, Paper Packaging

Reed-Lanehas Expanded Its 132,000ft2 Facility by 30% to Increase Its Overall Production

Jul 24, 2014

Reed-Lane, a contract packaging provider in New Jersey, has expanded its 132,000ft2 facility by 30% to increase its overall production. As part of the expansion, the company is also adding fifth bottling line to the facility that includes ...

Tags: Reed-Lane, overall production, Packaging

ANI Pharmaceuticals Inc. Entered Into a Fee-for-Service Development Agreement

Jan 14, 2014

ANI Pharmaceuticals Inc., an emerging generic pharmaceutical company, has entered into a fee-for-service development agreement for a generic drug product with Sterling Pharmaceutical Services ("Sterling"). The product will be developed by ...

Tags: ANI Pharmaceuticals Inc, pharmaceutical company, Sterling

Show Slower Growth in Health Spending Since The Implementation of The Affordable Care Act

Jan 8, 2014

Today, the Centers for Medicare and Medicaid Services (CMS) issued findings that show slower growth in health spending since the implementation of the Affordable Care Act. This successful cost control is consistent with data demonstrating ...

Tags: Centers for Medicare and Medicaid Services, health spending

Drug Preserved The Quality of Life in Patients with Familial Transthyretin Amyloidosis

Dec 27, 2013

A recent study led by researchers from the Amyloidosis Center at Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) demonstrates that diflunisal, a generic anti-inflammatory drug, successfully reduced neurological ...

Tags: diflunisal, anti-inflammatory drug, transthyretin amyloidosis, arthritis

80% Doctors Who Treat Cancer Were Unable to Prescribe Medication Because of Drug Shortage

Dec 25, 2013

Four out of five doctors who treat cancer were unable to prescribe their medication of choice at least once during a six-month period because of a drug shortage, according to a new survey. The survey also found that more than 75 percent ...

Tags: drug shortage, chemotherapy drugs, cancer doctors

Monoclonal Antibody Agents Have Been Successfully Used in The Treatment of Tumors

Dec 23, 2013

Currently, monoclonal antibody agents have been successfully used in the treatment of tumors, cancers and other serious diseases as a heavyweight in the biopharmaceutical industry. In 2009-2012, the market size of monoclonal antibody agents ...

Tags: Health, Medicine, Monoclonal Antibody Industry

FDA and EMA Have Announced The Launch of a Joint Initiative to Share Information

Dec 20, 2013

The US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have announced the launch of a joint initiative to share information on inspections of bioequivalence studies submitted in support of generic drug approvals. ...

Tags: Generic Drug, Medicine

Pharmaceutical Industry Demands for UPW Will Result in Purchases Close to $500 Million

Dec 9, 2013

The pharmaceutical industry demands for UPW for injection (WFI) and UPW for cleaning process equipment and other uses will result in purchases close to $500 million in 2017 up from $425 million this year. This is the latest forecast in the ...

Tags: consumables, health

China Is Planning Investments Regulations Which Will Result in Very Large Opportunities

Oct 24, 2013

China is planning investments and adjusting regulations which will result in very large opportunities for suppliers of flow control and treatment equipment. These opportunities are analyzed in Air/Gas/Water/Fluid Treatment and Control: ...

Tags: Treatment Equipment, Flow Control

FDA Laid out The Kind of Scientific Studies Generic Companies Need to Submit

Sep 12, 2013

One of the world's top-selling drugs—GlaxoSmithKline PLC's $8-billion-a-year asthma treatment Advair—became more vulnerable to generic competition after the U.S. Food and Drug Administration issued guidance on the regulatory ...

Tags: Health, Medicine

Upsher-Smith Will Launch The Generic Version of Its Morphine Sulfate ER Capsules

Sep 3, 2013

US-based specialty pharmaceutical firm Upsher-Smith Laboratories will launch the generic version of its Morphine Sulfate extended-release (ER) capsules, CII on 4 September 2013. Morphine Sulfate ER Capsules, CII are currently available in ...

Tags: ER Capsules, pharmaceutical

India Partly Suspended Patents Granted to Roche Holding for Breast Cancer Drug Herceptin

Aug 6, 2013

India has partly suspended patents granted to Roche Holding for its breast cancer drug Herceptin, over issues that the patents had not been filed in accordance with the laid down process. An article published in Swiss newspaper Schweiz am ...

Tags: Cancer Drug Patent

The EC Has Imposed a Fine of €146m on Nine Pharma Companies

Jun 21, 2013

The European Commission (EC) has imposed a fine of €146m on nine pharma companies, including Ranbaxy Laboratories, for blocking the entry of cheaper generic drug of Lundbeck's anti-depressant, citalopram. Lundbeck agreed with each of ...

Tags: Ranbaxy, Halting Generic Drugs

Astrazeneca Has Suspended Expansion in The Chinese Generic Drug Market

Jun 3, 2013

Leading global biopharmaceutical firm AstraZeneca has suspended expansion in the Chinese generic drug market. It announced adjustments on strategy for business in the Chinese mainland days ago and according to the adjustments, it will ...

Tags: Generic Drug Market, Health, Medicine

Generic Drug

Related Products